title: Cell sheet technology for heart failure.
abstract: Heart failure is a life threatening disorder in worldwide and many papers reported about myocardial regeneration through surgical method induced by LVAD, cellular cardiomyoplasty (cell injection), tissue cardiomyoplasty (bioengineered cardiac graft implantation), in situ engineering (scaffold implantation), and LV restrictive devices. Some of these innovated technologies have been introduced to clinical settings. This review article provides summary about recent basical and clinical advances about myocardial regeneration induced by bioengineered cardiac tissue.
authors: Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. sawa-p@surg1.med.osaka-u.ac.jp
authors: Yoshiki
authors: Y
authors: Sawa
authors: Shigeru
authors: S
authors: Miyagawa
mesh_terms: D000818:Animals; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D032386:Myoblasts, Cardiac / Q000637:transplantation*; D032383:Myocytes, Cardiac / Q000637:transplantation; D012038:Regeneration; D023822:Tissue Engineering / Q000379:methods*